| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5687185 | The Journal of Urology | 2017 | 32 Pages |
Abstract
The efficacy of onabotulinumtoxinA and solifenacin was significantly higher than that of placebo. However, onabotulinumtoxinA showed significantly greater decreases in urinary incontinence than solifenacin with a third of patients achieving a 100% incontinence reduction. No unexpected safety signals were observed.
Keywords
OnabotulinumtoxinATBSKHQUTIABCCICQOLOABKing’s Health QuestionnaireMIDQuality of lifeTEAECholinergic antagonistsITTUrgency urinary incontinenceUrinary incontinenceOveractiveMinimally important differencepost-void residual urine volumebotulinum toxinsPVRadverse eventurinary tract infectionIntent to treatUrinary bladderOveractive bladderUUIclean intermittent catheterization
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sender Herschorn, Alfred Kohan, Philip Aliotta, Kurt McCammon, Rajagopalan Sriram, Steven Abrams, Wayne Lam, Karel Everaert,